| |
|
|
|
CfPA - The Center for Professional Advancement, 90 Minute Accredited Online Training
July 2, 2013 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend
Professionals in the cosmetic and personal care or related industries that work and specialize in the following disciplines, as well as groups or companies that provide services in personal care in the following fields:
• Research and Development
• Regulatory Affairs
• Safety Assessment
• Product Development
• Formulations Development Description
This course will be available On Demand: July 3, 2013
Compounds that can change the genetic information of a living cell may lead to mutations. These can result in a variety of toxic effects, ranging from cell death to the development of a malignant tumor. Since there are apparent relationships between mutagenicity and carcinogenicity, genotoxicity screening assays are considered of value in identifying compounds with potential carcinogenic effect and are widely used in risk assessment. While a variety of assay are currently in use in the area of regulatory genotoxicity, still, substantial in vivo testing is required for the confirmation of genotoxic prediction. Genotoxicity testing requires separate assays for measurement of gene mutations and chromosomal damage.
This 90-minute accredited training will define genotoxicity, mutagenicity and carcinogenicity, provide updates issued by regulatory entities and specify examples for in vitro protocol to evaluate gene mutations and chromosomal damage.
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Nava Dayan Ph.D., President, Dr. Nava Dayan LLC
Dr. Nava Dayan is an independent consultant offering a wide range of services for the Pharmaceutical, Cosmetic, Personal Care, Research Entities, Regulatory and Government Agencies and other organizations and institutions that are interested in skin health and science. A skin care and health expert, Dr. Dayan has over 24 years of experience in a variety of skin research and development schemes in the Personal Care, Cosmetics, Pharmaceutical, Medical Devices and Delivery System Industries. Expertise include product innovation, skin biochemistry, development of ingredients and formulations, skin delivery and delivery systems for dermal and transdermal applications, prevention of adverse effects, safety assessment (skin toxicology; in vitro methodologies), claim substantiation via clinical study design, execution and data interpretation.
Dr. Dayan’s major strengths and interests include: skin aging, skin inflammatory disorders, delivery systems for enlargement of therapeutic index, natural ingredients and formulations, skin’s innate immunity and barrier integrity, biochemical paths analysis, gene expression, skin research of toxicological endpoint and their assessment.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|